tiprankstipranks
Plus Therapeutics Inc (PSTV)
NASDAQ:PSTV

Plus Therapeutics (PSTV) Financial Statements

522 Followers

Plus Therapeutics Financial Overview

Plus Therapeutics's market cap is currently ―. The company's EPS TTM is $-4.502; its P/E ratio is -0.38; Plus Therapeutics is scheduled to report earnings on August 12, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 1.24M$ 1.85M$ 506.00K$ 224.00K$ 0.00
Gross Profit$ 1.24M$ 1.85M$ 506.00K--
EBIT$ -3.13M$ -1.37M$ -4.67M$ -5.50M$ -5.05M
EBITDA$ -2.90M$ -1.13M$ -4.42M$ -5.34M$ -4.89M
Net Income Common Stockholders$ -3.22M$ -1.48M$ -4.80M$ -5.66M$ -5.22M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 11.01M$ 10.89M$ 12.72M$ 18.12M$ 20.27M
Total Assets$ 13.28M$ 14.20M$ 15.64M$ 23.87M$ 23.10M
Total Debt$ 4.58M$ 4.96M$ 5.33M$ 5.64M$ 6.00M
Net Debt$ -6.42M$ -5.94M$ -7.39M$ -12.47M$ -14.27M
Total Liabilities$ 10.66M$ 11.54M$ 12.96M$ 17.42M$ 11.70M
Stockholders Equity$ 2.62M$ 2.63M$ 2.68M$ 6.45M$ 11.40M
Cash Flow-
Free Cash Flow$ -2.41M$ -2.81M$ -5.88M$ -2.25M$ -4.00M
Operating Cash Flow$ -2.40M$ -2.80M$ -5.79M$ -2.23M$ -4.22M
Investing Cash Flow$ -10.00K$ -11.00K$ -97.00K$ -11.00K$ -33.00K
Financing Cash Flow$ 2.52M$ 961.00K$ 493.00K$ 99.00K$ 6.43M
Currency in USD

Plus Therapeutics Earnings and Revenue History

Plus Therapeutics Debt to Assets

Plus Therapeutics Cash Flow

Plus Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis